Results 21 to 30 of about 12,993 (261)

Nachbetreuung von PatientInnen mit „sustained virologic response“ [PDF]

open access: yesJournal für Gastroenterologische und Hepatologische Erkrankungen, 2020
ZusammenfassungDa die Therapie der chronischen Hepatitis C aufgrund der neuen direkt antiviral wirkenden Therapeutika („direct-acting antivirals“, DAA) aus virologischer Sicht bei nahezu allen PatientInnen zur nachhaltigen Ausheilung („sustained virologic response“, SVR) der Infektion führt, hat sich das Hauptaugenmerk auf Eliminationsprojekte sowie ...
Georg Semmler, Mattias Mandorfer
openaire   +1 more source

Letter: sustained virological response and liver healing – authors' reply [PDF]

open access: yesAlimentary Pharmacology & Therapeutics, 2017
Linked ContentThis article is linked to Rossotti et al and Schwabl et al papers. To view these articles visit https://doi.org/10.1111/apt.13982 and https://doi.org/10.1111/apt.13844.
M. Mandorfer   +3 more
openaire   +2 more sources

Early predictive efficacy of core antigen on antiviral outcomes in genotype 1 hepatitis C virus infected patients

open access: yesBrazilian Journal of Infectious Diseases, 2015
Response-guided therapy is of limited use in developing countries because hepatitis C virus RNA detection by sensitive molecular methods is time- and labor-consuming and expensive.
Bo Feng   +8 more
doaj   +1 more source

SUSTAINED VIROLOGIC RESPONSE RATE IN CHRONIC HEPATITIS C PATIENTS THROUGH DIRECT-ACTING ANTIVIRALS THERAPY [PDF]

open access: yesArquivos de Gastroenterologia, 2019
BACKGROUND: In recent years the management of hepatitis C virus infection and the possibility of its eradication have been researched due to the importance that they represent in the health of the world population.
Andréa Delfino TORRES   +3 more
doaj   +1 more source

Beyond the achievement of sustained virological response after liver transplantation [PDF]

open access: yesLiver International, 2015
See Articles on Page 2433 and ...
Sabela, Lens   +2 more
openaire   +2 more sources

Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients

open access: yesGut and Liver, 2017
Background/AimsThe approval of sofosbuvir (SOF), a direct-acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV).Methods : We assessed the sustained virological response (SVR) of SOF-based regimens in a real-world single ...
Hyun Phil Shin   +8 more
doaj   +1 more source

NAFLD‐related hepatocellular carcinoma: The growing challenge

open access: yesHepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah   +2 more
wiley   +1 more source

Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B

open access: yesClinics, 2013
OBJECTIVES: Suppressor of cytokine signaling 3, myxovirus resistance protein and osteopontin gene polymorphisms may influence the therapeutic response in patients with chronic hepatitis C, and an association with IL28 might increase the power to predict ...
Ana Luiza Dias Angelo   +8 more
doaj   +1 more source

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis

open access: yesHepatology, EarlyView., 2022
Adaptive mitochondrial mechanisms allow mitochondrial resilience and prevent the worsening of fibrosis, while deregulation of these mechanisms promotes the progression from no/minimal‐mild (F0‐F2) fibrosis to advanced fibrosis and cirrhosis (F3‐F4). Abstract Background and Aims Hepatitis B virus (HBV) infection causes oxidative stress (OS) and alters ...
Dimitri Loureiro   +17 more
wiley   +1 more source

Epidemiological characteristics and real‐world treatment outcomes of hepatitis C among HIV/HCV co‐infected patients in Myanmar: A prospective cohort study

open access: yesHealth Science Reports, 2023
Background and Aims In Myanmar, public sector treatment programs for hepatitis C virus (HCV) infection were nonexistent until June 2017. WHO highlights the importance of simplification of HCV service delivery through task‐shifting among health workers ...
Thein Min Swe   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy